GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Labo Euromedis (FRA:61R) » Definitions » EPS (Basic)

Labo Euromedis (FRA:61R) EPS (Basic) : €6.32 (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Labo Euromedis EPS (Basic)?

Labo Euromedis's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was €-0.19. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was €6.32.

Labo Euromedis's EPS (Diluted) for the six months ended in Jun. 2024 was €-0.19. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €6.32.

Labo Euromedis's EPS without NRI for the six months ended in Jun. 2024 was €-0.18. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was 9.23.

During the past 3 years, the average EPS without NRI Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 14 years, Labo Euromedis's highest 3-Year average EPS without NRI Growth Rate was 240.40% per year. The lowest was -70.90% per year. And the median was 18.50% per year.


Labo Euromedis EPS (Basic) Historical Data

The historical data trend for Labo Euromedis's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labo Euromedis EPS (Basic) Chart

Labo Euromedis Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.22 7.53 0.75 -1.97 4.60

Labo Euromedis Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.00 0.02 -1.91 6.51 -0.19

Labo Euromedis EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Labo Euromedis's Basic EPS for the fiscal year that ended in Dec. 2022 is calculated as

Basic EPS (A: Dec. 2022 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-5.933-0)/3.010
=-1.97

Labo Euromedis's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.532-0)/2.849
=-0.19

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €6.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labo Euromedis  (FRA:61R) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Labo Euromedis EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Labo Euromedis Business Description

Traded in Other Exchanges
Address
ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.

Labo Euromedis Headlines

No Headlines